<p>A: representative immunoblots of Cox-2, PKC-α, P-gp compared with β-actin in different treatment groups. (lane 1): NS control group (SGC7901/ADR) (lane 2): TWEEN control group (SGC7901/ADR) (lane 3): ADR group (SGC7901/ADR) (lane 4): PAB group (SGC7901/ADR) (lane 5): PAB+ADR group (SGC7901/ADR) (lane 6): NS control group (SGC7901). B: relative expression levels of Cox-2 (B1), PKC-α (B2), and P-gp (B3) in different treatment groups. The tumors were isolated and homogenized to measure the protein level, and β-actin was used as an internal control. Each immunoblot was representative of three distinct experiments with similar results. *<i>p</i><0.05 vs control group.</p
<p><b>(A)</b> Western blot analysis of expression levels of COX1, COX2, 15-PGDH, and PTGR2 in PL45, ...
<p>(A) Macroscopic pictures were obtained at the same magnification from bottom and side view. (B) T...
<p>(A–D), SW480 and LoVo cells were treated with UA for 48 h. The expression of COX-2 protein (<b>A<...
<p>Notes: * p<0.05 vs control group.</p><p>Rtv/Ctv (%) = (Relative tumor volume in treatment group...
<p>(A) Immunoblots using antibodies against PPARγ, cyclin A, cyclin D1, p16, or beta-actin were used...
<p>Fibroblasts from nasal mucosa (NM, N = 5, black spots) and nasal polyps from AIA patients (NP-AIA...
<p>(A) RAW264.7 cells were pre-treated for 30 minutes with MK591 or vehicle followed by LPS or Lipid...
<p>A) IEC-6 cells were treated with the indicated concentrations of LPS for 24 hours. B) IEC-6 cells...
<p>A, MCF-7 cells were treated with theaflavins or celecoxib or transfected with Cox-2-siRNA and the...
<p><b>A</b>. RPS reduced the expression of COX-2 and cyclin D1 in esophageal cancer cells. EC9706 ce...
<p>(A–B) COX-2 and mPGES-1 expression (western blot) in HUVEC treated with BK (1 µM) for the indicat...
<p>A, Cells were treated for 24 hrs with PHTPP (100nm), E2 + PHTPP or DPN + PHTPP. (n = 5). B, Weste...
<p>(A) P-gp was overexpressed in resistant breast cancer cells compared with parent cells. NPB304 tr...
<p>(A) MCF-7 cells were individually or co-treated with 20 ng/mL PMA, 1 mM PKC412 and 0.1 mM Go 6983...
<p>(<b>A</b>) Analysis of PKCδ protein levels in SF- and SR-HsFb with or without PMA treatment. PKCδ...
<p><b>(A)</b> Western blot analysis of expression levels of COX1, COX2, 15-PGDH, and PTGR2 in PL45, ...
<p>(A) Macroscopic pictures were obtained at the same magnification from bottom and side view. (B) T...
<p>(A–D), SW480 and LoVo cells were treated with UA for 48 h. The expression of COX-2 protein (<b>A<...
<p>Notes: * p<0.05 vs control group.</p><p>Rtv/Ctv (%) = (Relative tumor volume in treatment group...
<p>(A) Immunoblots using antibodies against PPARγ, cyclin A, cyclin D1, p16, or beta-actin were used...
<p>Fibroblasts from nasal mucosa (NM, N = 5, black spots) and nasal polyps from AIA patients (NP-AIA...
<p>(A) RAW264.7 cells were pre-treated for 30 minutes with MK591 or vehicle followed by LPS or Lipid...
<p>A) IEC-6 cells were treated with the indicated concentrations of LPS for 24 hours. B) IEC-6 cells...
<p>A, MCF-7 cells were treated with theaflavins or celecoxib or transfected with Cox-2-siRNA and the...
<p><b>A</b>. RPS reduced the expression of COX-2 and cyclin D1 in esophageal cancer cells. EC9706 ce...
<p>(A–B) COX-2 and mPGES-1 expression (western blot) in HUVEC treated with BK (1 µM) for the indicat...
<p>A, Cells were treated for 24 hrs with PHTPP (100nm), E2 + PHTPP or DPN + PHTPP. (n = 5). B, Weste...
<p>(A) P-gp was overexpressed in resistant breast cancer cells compared with parent cells. NPB304 tr...
<p>(A) MCF-7 cells were individually or co-treated with 20 ng/mL PMA, 1 mM PKC412 and 0.1 mM Go 6983...
<p>(<b>A</b>) Analysis of PKCδ protein levels in SF- and SR-HsFb with or without PMA treatment. PKCδ...
<p><b>(A)</b> Western blot analysis of expression levels of COX1, COX2, 15-PGDH, and PTGR2 in PL45, ...
<p>(A) Macroscopic pictures were obtained at the same magnification from bottom and side view. (B) T...
<p>(A–D), SW480 and LoVo cells were treated with UA for 48 h. The expression of COX-2 protein (<b>A<...